Enovis ENOV
NYSE ENOV
$26.06 -0.12 (-0.46%)
At close: Aug 21, 2026 · 4:00 PM EDT

Enovis (ENOV) Current Deferred Tax Assets (2010 - 2011)

Enovis (ENOV) posted quarterly Current Deferred Tax Assets of $9.4 million for Q4 2011, up 54.01% year-over-year from $6.1 million in Q4 2010, and up 47.82% quarter-over-quarter from $6.4 million in Q3 2011.

Enovis (ENOV) Current Deferred Tax Assets (2010 - 2011) Analysis & Trends

Enovis (ENOV) has reported Current Deferred Tax Assets for 2 consecutive years, with $9.4 million the latest figure, recorded in Q4 2011.

  • In Q4 2011, Current Deferred Tax Assets rose 54.01% year-over-year to $9.4 million; the TTM figure through Dec 2011 stood at $9.4 million (up 54.01% YoY), while the FY2011 annual figure was $9.4 million, up 54.01% from the prior year.
  • Current Deferred Tax Assets climbed to $9.4 million in Q4 2011 per ENOV's latest filing, from $6.4 million in the prior quarter.
  • Across five years, Current Deferred Tax Assets topped out at $9.4 million in Q4 2011 and bottomed at $6.1 million in Q4 2010.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn
10 Enovis 1.51 Bn 1.50 Bn 359.25 Mn

Historic Data

Download Data
DateValue
Dec 31, 2011 9.41 Mn
Dec 31, 2011 9.41 Mn
Sep 30, 2011 6.36 Mn
Sep 30, 2011 6.36 Mn
Jul 1, 2011 6.57 Mn
Jul 1, 2011 6.57 Mn
Dec 31, 2010 6.11 Mn
Dec 31, 2010 6.11 Mn